IFNGR2 抗体
(Interferon gamma Receptor 2 (Interferon gamma Transducer 1) (IFNGR2))
This gene (IFNGR2) encodes the non-ligand-binding beta chain of the gamma interferon receptor. Human interferon-gamma receptor is a heterodimer of IFNGR1 and IFNGR2. Defects in IFNGR2 are a cause of mendelian susceptibility to mycobacterial disease (MSMD), also known as familial disseminated atypical mycobacterial infection. MSMD is a genetically heterogeneous disease with autosomal recessive, autosomal dominant or X-linked inheritance. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| IFNGR2 抗体 (AA 20-332) (Fluoro594) | 小鼠 | 兔 Polyclonal |
|
|
|
| IFNGR2 抗体 (AA 20-332) | 小鼠 | 兔 Polyclonal |
|
|
|
| IFNGR2 抗体 (AA 20-332) (FITC) | 小鼠 | 兔 Polyclonal |
|
|
|
| IFNGR2 抗体 (AA 20-332) (Cy3) | 小鼠 | 兔 Polyclonal |
|
|
|
| IFNGR2 抗体 (AA 20-332) (Fluoro488) | 小鼠 | 兔 Polyclonal |
|
|
|
| IFNGR2 抗体 (AA 20-332) (Fluoro647) | 小鼠 | 兔 Polyclonal |
|
|
|
| IFNGR2 抗体 (AA 20-332) (PE) | 小鼠 | 兔 Polyclonal |
|
|
|
| IFNGR2 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| IFNGR2 抗体 (C-Term) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| IFNGR2 抗体 (AA 21-243) | 小鼠 | 仓鼠 Monoclonal |
|
|
|
| IFNGR2 抗体 | 人 | 小鸡 Polyclonal |
|
|
|
| IFNGR2 抗体 | 小鼠 | 兔 Polyclonal |
|
|
|
| IFNGR2 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| IFNGR2 抗体 (APC) | 人 | 小鼠 Monoclonal |
|
|
|
| IFNGR2 抗体 (FITC) | 人 | 小鼠 Monoclonal |
|
|
|
| IFNGR2 抗体 (PerCP) | 人 | 小鼠 Monoclonal |
|
|
|
| IFNGR2 抗体 (PE) | 人 | 小鼠 Monoclonal |
|
|
|
| IFNGR2 抗体 | 人 | 兔 Polyclonal |
|
|
|
| IFNGR2 抗体 (AA 28-205) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| IFNGR2 抗体 | 人 | 小鼠 Monoclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro594
- 抗体亚型
- IgG
- 抗原表位
- AA 20-332
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 20-332
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 20-332
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- AA 20-332
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro488
- 抗体亚型
- IgG
- 抗原表位
- AA 20-332
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro647
- 抗体亚型
- IgG
- 抗原表位
- AA 20-332
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 20-332
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term, AA 308-337
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- C-Term, AA 308-337
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- Neut (Neutralization: 所列应用)
- 适用
- 小鼠
- 宿主
- 仓鼠
- 克隆形成能力
- Monoclonal
- 克隆
- RM0252-7A25
- 标记
- unconjugated
- 抗体亚型
- IgG2
- 抗原表位
- AA 21-243
Primary Antibody
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- ABS1340
- 标记
- PerCP
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 28-205
Latest Publications for our IFNGR2 抗体
: "Aberrant expression of NKL homeobox gene HLX in Hodgkin lymphoma." in: Oncotarget, Vol. 9, Issue 18, pp. 14338-14353, (2018) (PubMed).
: "CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy." in: BMC cancer, Vol. 16, pp. 15, (2016) (PubMed).
: "Trisomy 21 consistently activates the interferon response." in: eLife, Vol. 5, (2016) (PubMed).
: "Glycosylation-Dependent IFN-γR Partitioning in Lipid and Actin Nanodomains Is Critical for JAK Activation." in: Cell, Vol. 166, Issue 4, pp. 920-934, (2016) (PubMed).
: "Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy." in: PLoS pathogens, Vol. 8, Issue 1, pp. e1002480, (2012) (PubMed).
: "Expression of trisomic proteins in Down syndrome model systems." in: Gene, Vol. 512, Issue 2, pp. 219-25, (2012) (PubMed).
: "Inclusion body myositis: laser microdissection reveals differential up-regulation of IFN-γ signaling cascade in attacked versus nonattacked myofibers." in: The American journal of pathology, Vol. 179, Issue 3, pp. 1347-59, (2011) (PubMed).
: "Effect of amino acid substitutions in the human IFN-γR2 on IFN-γ responsiveness." in: Genes and immunity, Vol. 12, Issue 2, pp. 136-44, (2011) (PubMed).
: "Differential expression of interferon-gamma receptor on human glial cells in vivo and in vitro." in: Journal of neuroimmunology, Vol. 225, Issue 1-2, pp. 91-9, (2010) (PubMed).
: "Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells." in: Neurobiology of aging, Vol. 30, Issue 12, pp. 1924-35, (2009) (PubMed).
: "CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy." in: BMC cancer, Vol. 16, pp. 15, (2016) (PubMed).
: "Trisomy 21 consistently activates the interferon response." in: eLife, Vol. 5, (2016) (PubMed).
: "Glycosylation-Dependent IFN-γR Partitioning in Lipid and Actin Nanodomains Is Critical for JAK Activation." in: Cell, Vol. 166, Issue 4, pp. 920-934, (2016) (PubMed).
: "Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy." in: PLoS pathogens, Vol. 8, Issue 1, pp. e1002480, (2012) (PubMed).
: "Expression of trisomic proteins in Down syndrome model systems." in: Gene, Vol. 512, Issue 2, pp. 219-25, (2012) (PubMed).
: "Inclusion body myositis: laser microdissection reveals differential up-regulation of IFN-γ signaling cascade in attacked versus nonattacked myofibers." in: The American journal of pathology, Vol. 179, Issue 3, pp. 1347-59, (2011) (PubMed).
: "Effect of amino acid substitutions in the human IFN-γR2 on IFN-γ responsiveness." in: Genes and immunity, Vol. 12, Issue 2, pp. 136-44, (2011) (PubMed).
: "Differential expression of interferon-gamma receptor on human glial cells in vivo and in vitro." in: Journal of neuroimmunology, Vol. 225, Issue 1-2, pp. 91-9, (2010) (PubMed).
: "Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells." in: Neurobiology of aging, Vol. 30, Issue 12, pp. 1924-35, (2009) (PubMed).
Aliases for IFNGR2 抗体
interferon gamma receptor 2 (Ifngr2) 抗体interferon gamma receptor 2 (IFNGR2) 抗体
interferon gamma receptor 2 (LOC487739) 抗体
AF-1 抗体
Ifgr2 抗体
IFGR2 抗体
Ifgt 抗体
IFNGT1 抗体
您还需要查找其他产品吗？
You are here:
